Gastkommentar zur AWMF-S2k Leitlinie 024/020 „Prophylaxe der Neugeborenensepsis – frühe Form – durch Streptokokken der Gruppe B“

Reinhard Berner

doi:10.1055/s-0043-106947

Zeitschrift für Geburtshilfe und Neonatologie, Inhaltsverzeichnis

Z Geburtshilfe Neonatol 2017; 221(03): 130-131
DOI: 10.1055/s-0043-106947

Kommentar

Gastkommentar zur AWMF-S2k Leitlinie 024/020 „Prophylaxe der Neugeborenensepsis – frühe Form – durch Streptokokken der Gruppe B“

Authors

Reinhard Berner

Abstract

Volltext

Referenzen

Literatur
1 Franz A, Härtel C, Herting E. et al. Prophylaxe der Neugeborenensepsis – frühe Form – durch Streptokokken der Gruppe B. Leitlinie des BVF, BVDfK, der DGGG, DGHM, DGPI, DGPM und GNPI. (S2k-Level, AWMF-Registernummer 024/020, März 2016). Z Geburtsh Neonatol 2017; 221: 122-129
2 Edmond KM, Kortsalioudaki C, Scott S. et al. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet 2012; 379: 547-556
3 Schrag SJ, Farley MM, Petit S et al. Epidemiology of invasive early-onset neonatal sepsis, 2005 to 2014. Pediatrics 2016; 138: pii: e20162013
4 Fluegge K. Supper S, Siedler A, Berner R. Serotype distribution of invasive Group B Streptococcal isolates in neonates: results from a nationwide active laboratory surveillance study over 2 years in Germany. Clin Infect Dis 2005; 40: 760-763
5 Schrag SJ, Zywicki S, Farley MM. et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000; 342: 15-20
6 Kobayashi M, Schrag SJ, Alderson MR et al. WHO consultation on group B Streptococcus vaccine development: report from a meeting held on 27-28 April 2016. Vaccine 2016 pii: S0264-410X(16)31236-1
7 Schuchat A. Group B streptococcal disease: from trials and tribulations to triumph and trepidation. Clin Infect Dis 2001; 33: 751-756
8 Heyderman RS, Madhi SA, French N. et al. Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial. Lancet Infect Dis 2016; 16: 546-555
9 Fabbrini M, Rigat F, Rinaudo CD. et al. The protective value of maternal group B streptococcus antibodies: quantitative and functional analysis of naturally acquired responses to capsular polysaccharides and pilus proteins in European maternal sera. Clin Infect Dis 2016; 63: 746-753
10 Berner R. En route towards prevention of neonatal group B streptococcal disease. Lancet Infect Dis 2016; 16: 509-510
11 Libster R, Edwards KM, Levent F. et al. Long-term outcomes of group B streptococcal meningitis. Pediatrics 2012; 130: e8-e15